NO308580B1 - Anvendelse av kondenserte cykliske forbindelser for fremstilling av en antihypertriglyceridemisk medisin - Google Patents
Anvendelse av kondenserte cykliske forbindelser for fremstilling av en antihypertriglyceridemisk medisinInfo
- Publication number
- NO308580B1 NO308580B1 NO953961A NO953961A NO308580B1 NO 308580 B1 NO308580 B1 NO 308580B1 NO 953961 A NO953961 A NO 953961A NO 953961 A NO953961 A NO 953961A NO 308580 B1 NO308580 B1 NO 308580B1
- Authority
- NO
- Norway
- Prior art keywords
- hypertriglyceridemic
- drug
- preparation
- cyclic compounds
- condensed cyclic
- Prior art date
Links
- 230000001346 anti-hypertriglyceridemic effect Effects 0.000 title 1
- 150000001923 cyclic compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24413694 | 1994-10-07 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953961D0 NO953961D0 (no) | 1995-10-05 |
| NO953961L NO953961L (no) | 1996-04-09 |
| NO308580B1 true NO308580B1 (no) | 2000-10-02 |
Family
ID=17114301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953961A NO308580B1 (no) | 1994-10-07 | 1995-10-05 | Anvendelse av kondenserte cykliske forbindelser for fremstilling av en antihypertriglyceridemisk medisin |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0705607A2 (enExample) |
| KR (1) | KR960013370A (enExample) |
| CN (1) | CN1128657A (enExample) |
| AU (1) | AU703422B2 (enExample) |
| CA (1) | CA2160092A1 (enExample) |
| FI (1) | FI954773A7 (enExample) |
| HU (1) | HUT73422A (enExample) |
| NO (1) | NO308580B1 (enExample) |
| NZ (1) | NZ280165A (enExample) |
| RU (1) | RU2166320C2 (enExample) |
| TW (1) | TW401301B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2158344T3 (es) * | 1995-09-13 | 2001-09-01 | Takeda Chemical Industries Ltd | Compuestos benzoxazepinicos, su produccion y uso como agentes reductores de lipidos. |
| CN1072649C (zh) * | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| WO1997047323A2 (en) * | 1996-06-11 | 1997-12-18 | Zonagen, Inc. | Chitosan drug delivery system |
| ATE309993T1 (de) | 1997-04-21 | 2005-12-15 | Takeda Pharmaceutical | 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten |
| JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
| US6214991B1 (en) | 1998-03-31 | 2001-04-10 | The Institute For Pharmaceutical Discovery, Inc. | Substituted indolealkanoic acids |
| US6207664B1 (en) | 1998-11-25 | 2001-03-27 | Pfizer Inc. | Squalene synthetase inhibitor agents |
| TNSN99224A1 (fr) * | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
| CA2370141A1 (en) | 1999-05-26 | 2000-12-07 | James D. Rodgers | 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| MXPA02001340A (es) * | 1999-08-05 | 2004-07-16 | Prescient Neuropharma Inc | Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos. |
| WO2002038180A1 (en) * | 2000-11-09 | 2002-05-16 | Takeda Chemical Industries, Ltd. | High-density lipoprotein-cholesterol level elevating agent |
| US7067148B2 (en) | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| US20030027786A1 (en) * | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
| US20040204500A1 (en) * | 2001-06-28 | 2004-10-14 | Yasuo Sugiyama | Preventives/remedies for organ functional disorders and organ dysfunction |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| US7625887B2 (en) | 2003-01-28 | 2009-12-01 | Takeda Pharmaceutical Company Limited | Receptor agonists |
| CN1882327A (zh) | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| CA2575014A1 (en) * | 2004-08-09 | 2006-02-16 | Takeda Pharmaceutical Company Limited | Crp lowering agent |
| US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
| JP2009512715A (ja) | 2005-10-21 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ |
| JP2010526825A (ja) | 2007-05-10 | 2010-08-05 | エーエムアール テクノロジー インコーポレイテッド | アリール置換およびヘテロアリール置換テトラヒドロベンゾ−１，４−ジアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用 |
| WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
| WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| EP4146205A4 (en) | 2020-05-05 | 2024-05-29 | Nuvalent, Inc. | HETEROAROMATIC MACROCYCLIC ETHERS AS CHEMOTHERAPEUTIC AGENTS |
| IL297832A (en) | 2020-05-05 | 2023-01-01 | Nuvalent Inc | Macrocyclic heteroaromatic chemotherapeutic agents |
| TW202320768A (zh) | 2021-10-01 | 2023-06-01 | 美商努法倫特公司 | 雜芳族大環醚化合物之固體形式、醫藥組成物及製備 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5180717A (en) * | 1988-08-16 | 1993-01-19 | The Upjohn Company | Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol |
| FR2659332B1 (fr) * | 1990-03-08 | 1994-04-29 | Adit Et Cie | Nouvelles pyrrolo [1,2-a] thieno [3,2-f] diazepines [1,4], leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| EP0567026B1 (en) * | 1992-04-20 | 2003-03-26 | Takeda Chemical Industries, Ltd. | 4,1-Benzoxazepin derivatives as squalene synthase inhibitors and their use in the treatment of hypercholesteremia and as fungicides |
| TW225992B (enExample) * | 1992-07-17 | 1994-07-01 | Senju Pharma Co | |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| WO1995021834A1 (en) * | 1994-02-09 | 1995-08-17 | Takeda Chemical Industries, Ltd. | Optically active 4,1-benzoxazepine derivatives useful as squalene synthase inhibitors |
-
1995
- 1995-09-21 TW TW084109892A patent/TW401301B/zh not_active IP Right Cessation
- 1995-09-26 EP EP95115109A patent/EP0705607A2/en not_active Withdrawn
- 1995-10-04 NZ NZ280165A patent/NZ280165A/en unknown
- 1995-10-05 NO NO953961A patent/NO308580B1/no not_active IP Right Cessation
- 1995-10-05 AU AU33081/95A patent/AU703422B2/en not_active Ceased
- 1995-10-05 HU HU9502918A patent/HUT73422A/hu unknown
- 1995-10-06 KR KR1019950034188A patent/KR960013370A/ko not_active Ceased
- 1995-10-06 FI FI954773A patent/FI954773A7/fi unknown
- 1995-10-06 CN CN95117761A patent/CN1128657A/zh active Pending
- 1995-10-06 RU RU95117068/14A patent/RU2166320C2/ru active
- 1995-10-06 CA CA002160092A patent/CA2160092A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FI954773A0 (fi) | 1995-10-06 |
| HUT73422A (en) | 1996-07-29 |
| EP0705607A3 (enExample) | 1996-05-08 |
| HU9502918D0 (en) | 1995-11-28 |
| CA2160092A1 (en) | 1996-04-08 |
| AU703422B2 (en) | 1999-03-25 |
| FI954773A7 (fi) | 1996-04-08 |
| KR960013370A (ko) | 1996-05-22 |
| RU2166320C2 (ru) | 2001-05-10 |
| NZ280165A (en) | 1997-07-27 |
| NO953961D0 (no) | 1995-10-05 |
| EP0705607A2 (en) | 1996-04-10 |
| NO953961L (no) | 1996-04-09 |
| AU3308195A (en) | 1996-04-18 |
| CN1128657A (zh) | 1996-08-14 |
| TW401301B (en) | 2000-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308580B1 (no) | Anvendelse av kondenserte cykliske forbindelser for fremstilling av en antihypertriglyceridemisk medisin | |
| NO900831D0 (no) | Fremgangsmaate for fremstilling av piperidinforbindelser. | |
| DK0941103T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
| NO912411D0 (no) | Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser. | |
| NO910395L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. | |
| NO905008D0 (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser. | |
| NO900774L (no) | Fremgangsmaate for fremstilling av polyamider. | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| NO924632D0 (no) | Fremgangsmaate for fremstilling av cykliske sulfater | |
| NO930574L (no) | Fremgangsmaate for fremstilling av desfluran | |
| NO991733D0 (no) | FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering | |
| NO920049D0 (no) | Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere | |
| FI935654A7 (fi) | Kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö | |
| NO994083D0 (no) | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser | |
| NO955082D0 (no) | Fremgangsmåte for fremstilling av glutardialdehyd | |
| NO306065B1 (no) | Fremgangsmåte for fremstilling av organoklorsilaner | |
| NO892432L (no) | Fremgangsmaate for fremstilling av kondenserte diazepinoner | |
| NO910186L (no) | Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat. | |
| NO903666L (no) | Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser. | |
| NO961008D0 (no) | Fremgangsmåte for fremstilling av cykliske cis-1-amino-2-alkanoler | |
| NO904535L (no) | Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser. | |
| NO903939L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner. | |
| NO924763L (no) | Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre | |
| NO903397D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
| NO972682D0 (no) | Ny fremgangsmåte for fremstilling av sameridin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2003 |